ASCO Recommends Against Routine Adjuvant Chemo For Stage II Colon Cancer
Exercise Improves Function, Symptoms Of Cancer Survivors, AHRQ Report Finds
Guideline Adherence Improves Early Breast Cancer Survival
Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says
FDA Approves Taxotere For Node+ Breast Cancer
FDA Approves Lilly’s Alimta For Metastatic NSCLC
Reduced Risk of Metastasis When Screening Finds Cancer
Ellence Has Lower Risk Of Heart Damage, Study Finds
Modality Combo Decreases Prostate Cancer Recurrence
Hormonal Therapy Improves Prostate Cancer Survival
Study Suggests Surveillance Colonoscopies Overperformed
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
